These findings suggest that certain RNA-binding proteins (RBPs) that regulate the alternative splicing of CD33 exon 2 influence the pathogenesis of AD, and possibly other neurodegenerative diseases, through modulating microglial activity. This evidence concerns the gene CD33 and Alzheimer disease.